Piper Sandler Reiterates Overweight on Moderna, Raises Price Target to $230
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsReiterationPrice TargetHot
Piper Sandler analyst Edward Tenthoff reiterates Moderna (NASDAQ:MRNA) with a Overweight and raises the price target from $167 to $230.
Piper Sandler analyst Edward Tenthoff reiterates Moderna (NASDAQ:MRNA) with a Overweight and raises the price target from $167 to $230.